Xcout Intel
Valanx Biotech
Valanx Biotech is a Vienna-based biotechnology company with around 15 employees, specializing in specific, fast, and cost-effective protein conjugation technologies.
Subscribe to see Valanx Biotech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Valanx Biotech at a glance
Valanx Biotech is a biotechnology company headquartered in Austria. It has raised at least $5.3M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $3.3M in March 2026. Xcout tracks 7 named people at Valanx Biotech, including Klaus Orlinger (Chief Scientific Officer).
Valanx Biotech leadership
- Klaus OrlingerChief Scientific Officer
- Michael LukeschCEO & Founder
- Georg AltenbacherCBO & Co-Founder
- Michael BoehlerMD (Chair)
- Alexander SchwartzPhD
- Ana MaricevicPhD
1 more named person on record for Valanx Biotech, with roles, board committees and tenure — see the full roster →
Valanx Biotech funding rounds
At least $5.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $3.3M | 7 named | |
| Series A | $2M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Valanx Biotech competitors
A few of Valanx Biotech's closest competitors — see the full list of competitors and alternatives →
Navigo Proteins GmbH is a biotechnology research company headquartered in Halle, Germany, specializing in precision protein engineering for life sciences. The firm develops engineered affinity proteins and tailored solutions for biopharmaceutical applications.
RJH Biosciences develops transfection reagents and nucleic acid delivery systems for various human cells, cell lines, and preclinical animal models. The company serves the biomedical research and development sector by providing tailored products and contract research services for applications such as mRNA, DNA, siRNA, and CRISPR delivery.
Headquartered in Hanover, Germany, Phaeosynt is a biotechnology company founded to produce animal-free antibodies using diatoms instead of traditional methods.
Immobazyme is a biotechnology company headquartered in Cape Town, South Africa, specializing in enzyme engineering, recombinant protein production, and functional protein manufacturing.
Genovis is a Swedish biotechnology company that develops and commercializes enzymes and enzyme-based technologies used in the development, characterization, and quality control of biopharmaceuticals. Its customers include pharmaceutical and biotechnology companies, as well as research and analytical laboratories.
Get Valanx Biotech's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Valanx Biotech in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access